title: Hepatitis B reverse seroconversion in a patient with well controlled HIV infection: a case report and a review of the literature.
authors.affiliation: aDepartment of Pharmacy Practice, Jefferson School of Pharmacy, Thomas Jefferson University, Philadelphia, Pennsylvania bJefferson School of Pharmacy, Thomas Jefferson University, Northeastern University, Lexington, Massachusetts cCubist Pharmaceuticals, Lexington, Massachusetts dJefferson Medical College, Division of Infectious Diseases, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
authors.forename: Jason J
authors.initials: JJ
authors.lastname: Schafer
authors.forename: Danielle
authors.initials: D
authors.lastname: Formella
authors.forename: Joseph A
authors.initials: JA
authors.lastname: Desimone
mesh_terms: D000368:Aged; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006509:Hepatitis B / Q000097:blood / Q000150:complications / Q000276:immunology*; D006510:Hepatitis B Antibodies / Q000097:blood*; D006511:Hepatitis B Antigens / Q000097:blood*; D006801:Humans; D008297:Male; D012698:Serologic Tests
chemical_list: D017320:HIV Protease Inhibitors; D006510:Hepatitis B Antibodies; D006511:Hepatitis B Antigens